⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman
prnewswire.com
MLTX
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – MLTX
globenewswire.com
MLTX
MLTX Class Action Reminder – Robbins LLP Reminds MoonLake Immunotherapeutics Stockholders of the Opportunity to Lead the Class Action Lawsuit
globenewswire.com
MLTX
MOONLAKE NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations after Stock Drops 90%, Investors Urged to Contact BFA Law
newsfilecorp.com
MLTX
MOONLAKE INVESTORS: MoonLake Immunotherapeutics (MLTX) has been Sued for Securities Fraud, Investors are Urged to Contact BFA Law
newsfilecorp.com
MLTX
Securities Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Represents Shareholders
newsfilecorp.com
MLTX
MLTX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
MoonLake Immunotherapeutics (MLTX) Class Action Deadline December 15 - Investors Notified to Contact BFA Law to Protect Your Rights
accessnewswire.com
MLTX